Funded Project Details - FY2021
|Title:|| GRM1-induced HIF-1? and reprogramming of glutamine metabolisms in melanoma|
||East Orange, NJ
|Congressional District Code:
||Biomedical Laboratory R&D
|| October 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
A new emerging hallmark for many malignancies is altered metabolic direction to support rapid cell proliferation. Considerable progress has been made in elucidating how modified cell signaling contributes to deregulated cell growth in cancer, much less is known regarding metabolic rewiring to provide for the demand in building blocks to support the ever-increasing cell numbers. Within the last few years metabolite profiling between normal and cancer cells has provided new insights to uncover the...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.